FUSOBACTERIUM AS A POTENTIAL PATHOGENETIC FACTOR IN ENDOMETRIOSIS: CURRENT EVIDENCE, METHODOLOGICAL CHALLENGES, AND CLINICAL IMPLICATIONS
Abstract
Background: Endometriosis is a chronic inflammatory gynecological disorder with an incompletely understood etiology. While hormonal, immunological, and genetic factors have been extensively studied, increasing attention has recently been directed toward the potential role of microbial agents in disease pathogenesis. Among these, Fusobacterium, particularly Fusobacterium nucleatum, has emerged as a candidate pathogen based on translational and experimental findings.
Objective: This narrative review aims to critically evaluate current evidence regarding the association between Fusobacterium and endometriosis, assess the biological plausibility of a pathogenic role, and identify methodological limitations and clinical implications.
Methods: A structured literature search was conducted in PubMed for publications addressing Fusobacterium in the context of endometriosis, including human studies, experimental models, and relevant commentaries. Evidence was synthesized thematically, with emphasis on study design, detection methods, and consistency of findings.
Results: Available data suggest that Fusobacterium may be present in endometrial tissues of some women with endometriosis and may promote inflammatory signaling and lesion development in experimental models. However, recent human studies have reported conflicting results, including a lack of significant Fusobacterium enrichment in eutopic endometrium. These discrepancies appear to be influenced by differences in patient selection, sampling strategies, low-biomass contamination risk, and microbiological detection techniques.
Conclusion: Although Fusobacterium represents a biologically plausible contributor to endometriosis pathophysiology, current evidence remains inconclusive. Further standardized, well-controlled studies are required before diagnostic or therapeutic strategies targeting this bacterium can be considered in clinical practice.
References
Chen, C., Song, X., Wei, W., Zhong, H., Dai, J., Lan, Z., Li, F., Yu, X., Feng, Q., Wang, Z., Xie, H., Chen, X., Zeng, C., Wen, B., Zeng, L., Du, H., Tang, H., Xu, C., Xia, Y., … Jia, H. (2017). The microbiota continuum along the female reproductive tract and its relation to uterine-related diseases. Nature Communications, 8(1), 875. https://doi.org/10.1038/s41467-017-00901-0
Ghosh, A., Jaaback, K., Boulton, A., Wong-Brown, M., Raymond, S., Dutta, P., Bowden, N. A., & Ghosh, A. (2024). Fusobacterium nucleatum: An Overview of Evidence, Demi-Decadal Trends, and Its Role in Adverse Pregnancy Outcomes and Various Gynecological Diseases, including Cancers. Cells, 13(8), 717. https://doi.org/10.3390/cells13080717
Graciano-España, M. C., Barnhart, K., Gonzalez-Monfort, M., Arenas-Barrero, M., Legro, R. S., Thomas, T. R., Rush, M. A., Vilella, F., Fernández-Sánchez, M., Simon, C., & Moreno, I. (2025). Fusobacterium nucleatum is not significantly present in eutopic endometrium from patients with minimal-mild and moderate-severe endometriosis. Fertility and Sterility, 124(5 Pt 2), 1071–1081. https://doi.org/10.1016/j.fertnstert.2025.06.035
Hicks, C., Leonardi, M., Chua, X.-Y., Mari-Breedt, L., Espada, M., El-Omar, E. M., Condous, G., & El-Assaad, F. (2025). Oral, Vaginal, and Stool Microbial Signatures in Patients With Endometriosis as Potential Diagnostic Non-Invasive Biomarkers: A Prospective Cohort Study. BJOG: An International Journal of Obstetrics and Gynaecology, 132(3), 326–336. https://doi.org/10.1111/1471-0528.17979
Hou, H.-T., Lin, T.-C., Wu, M.-H., & Tsai, S.-J. (2023). Feel so bac: Is Fusobacterium the suspect causing endometriosis? Trends in Molecular Medicine, 29(10), 780–782. https://doi.org/10.1016/j.molmed.2023.08.003
Khan, K. N., de Ziegler, D., & Guo, S.-W. (2024). Bacterial infection in endometriosis: A silver-lining for the development of new non-hormonal therapy? Human Reproduction (Oxford, England), 39(4), 623–631. https://doi.org/10.1093/humrep/deae006
Muraoka, A., Suzuki, M., Hamaguchi, T., Watanabe, S., Iijima, K., Murofushi, Y., Shinjo, K., Osuka, S., Hariyama, Y., Ito, M., Ohno, K., Kiyono, T., Kyo, S., Iwase, A., Kikkawa, F., Kajiyama, H., & Kondo, Y. (2023). Fusobacterium infection facilitates the development of endometriosis through the phenotypic transition of endometrial fibroblasts. Science Translational Medicine, 15(700), eadd1531. https://doi.org/10.1126/scitranslmed.add1531
Ul Ain, R. (2024). The etiology of endometriosis: Is Fusobacterium to blame? International Journal of Gynaecology and Obstetrics: The Official Organ of the International Federation of Gynaecology and Obstetrics, 166(3), 1363–1364. https://doi.org/10.1002/ijgo.15500
Venkatesan, P. (2023). Bacterial infection linked to endometriosis. The Lancet. Microbe, 4(10), e768. https://doi.org/10.1016/S2666-5247(23)00221-5
Views:
38
Downloads:
0
Copyright (c) 2026 Julia Hertmanowska, Paweł Jan Babiński, Magdalena Wiśniewska, Zuzanna Karolina Jędrzejczak, Andrzej Józef Horabik, Małgorzata Dmochowska, Marta Piotrowska, Krzysztof Chmura, Adrianna Alicja Piekarska, Gabriela Kryger
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
